Skip to main content

Table 1 Mouse models used to study canonical Wnt signaling in mammary development and cancer

From: Key signaling nodes in mammary gland development and cancer: β-catenin

Mouse model

Structural modification

Mammary phenotype

References

MMTV-ΔN89-β-catenin

Stabilizing deletion of first 89 amino acids of β-catenin

Luminal expression

Expansion K18+CD29hi 49flo

Precocious alveologenesis

Adenocarcinoma

[67, 75]

MMTV-ΔN90-β-catenin

Stabilizing deletion of first 90 amino acids of β-catenin

Luminal expression

Hyperplasia

Adenocarcinoma

[90]

Catnb+/lox(ex3);WAP-Cre

Stabilizing deletion of Exon 3 (codons 5 to 80) of β-catenin

Squamous metaplasia

[93]

Catnb+/lox(ex3);MMTV-Cre

Luminal expression

  

MMTV-ΔN90-β-catenin x

p53+/-

Stabilizing deletion of β-catenin on a p53 heterozygous background

Adenocarcinomas

[175]

 

Luminal expression

Metastases

 

K5-ΔN57-β-catenin

Stabilizing deletion of first 57 amino acids of β-catenin

Basal expression

Precocious development during pregnancy

Hyperbranching

Multiparous mice develop invasive basal-type carcinoma

[38, 74]

MMTV-Wnt1

Wnt1 expression in luminal epithelia

Expansion of K14+, cd24+, cd29/49fhi basal stem cells

Hyperbranching

Adenocarcinoma

[33, 67, 84, 85]

MMTV-Wnt10b

Expression of long isoform of Wnt10b in luminal epithelia

Precocious alveologenesis

Hyperbranching

Adenocarcinoma

[61]

MMTV-Lrp6

Expression of Lrp6 in luminal epithelia

Hyperplasia no tumors

[88]

ApcMin/+

Truncating mutation of APC at codon 850

Focal alveolar hyperplasias

Mammary carcinomas (7 to 20% depending on strain

background)

[178]

Apc+/1572

Truncating mutation of APC at codon 1572

Multifocal mammary adenocarcinomas (85.7%)

Pulmonary metastases

[95]

K14-cre-Apc580/+

Truncating mutation of APC at codon 580

Basal expression

Mammary adenocarcinomas

[94]

BLG-Cre; Apc580S/580S

Truncating mutation of APC at codon 580

Luminal expression

Delayed ductal morphogenesis

Metaplasia

[179]

MMTV-rtTA;TRE2-myc-

tagged Axin-(IRES) GFP

Doxycycline-inducible Axin in luminal epithelia

Loss of alveologenesis

[76]

WAP-β-engrailed

β-engrailed expressed luminally

Failure to maintain alveoli

[77]

MMTV-β-engrailed

 

Lactation defect

 

Lrp5-/-

Loss of Lrp5

Loss of placodes

Mild ductal hypoplasia

Reduced regenerative capacity

Resistant to Wnt-induced tumorigenesis

[34, 39]

Lrp6-/-

Loss of Lrp6

Impaired sprouting, placode and fat pad development

Decreased number of TEBs in heterozygotes

[40]

Wnt4-/-

Loss of Wnt4

Delayed side-branching

[69]

Wnt5a-/-

Loss of Wnt5a

Accelerated ductal morphogenesis

[64]

K5-rtTA/tetO-DKK1

Ectopic expression of Dkk1

Loss of mammary line and all placodal development

[36]

K14-Cre/Pygo2 flox

Loss of Pygo2 in mammary epithelium

Loss and small placodes

Progressive loss of progenitor cell population

[38]

Pin1-/-

Loss of Pin1

Severe decrease in ductal and alveolar development during pregnancy

[80]

RANK-/-

Loss of RANK receptor

Loss of alveologenesis

Failure to lactate

Impaired side-branching in transplanted null outgrowths

[78, 79]

Lef1-/-

Loss of Lef1

Impaired placodes

Impaired bud morphogenesis

[37]

Rspo-/-

Loss of Rspo1

Defective side branching

[73]

  1. APC, adenomatous polyposis coli; DKK, Dickkopf; GFP, green fluorescence protein; LRP, low-density lipoprotein-related protein; MMTV, mouse mammary tumor virus; Pygo2, pygopus homolog 2; RANK, receptor activator of NF-κB; TEB, terminal end bud; WAP, whey acidic protein.